Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03287817
Title CD19/22 CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma (ALEXANDER)
Acronym ALEXANDER
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Autolus Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR

Facility Status City State Zip Country Details
City of Hope Hospital Duarte California 91010 United States Details
Colorado Blood Cancer Institute at Presbyterian/St. Luke's Medical Center/Sarah Cannon Research Institute Denver Colorado 80218 United States Details
Sylvester Comprehensive Cancer Center / University of Miami Miami Florida 33136 United States Details
Siteman Cancer Center / Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
TriStar Centennial Medical Center /Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
St David's South Austin Medical Center /Sarah Cannon Research Institute Austin Texas 78704 United States Details
The Beatson West of Scotland Cancer Centre / Queen Elizabeth University Hospital Glasgow G12 0YN United Kingdom Details
University College London Hospitals NHS Foundation Trust London United Kingdom Details
Manchester University NHS Foundation Trust Manchester United Kingdom Details
Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field